Concord Drugs share news and announcements
BSE: 538965Pharmaceuticals & BiotechnologySmall Cap
Last close ₹68.06down ₹0.94 (1.36%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹69.00.
52-week range of traded prices to 23 Oct 2026
₹61.00Low, 23 Oct 2025₹92.52High, 13 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹90 Cr3,001st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- 43.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.28
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,703
Concord Drugs results
63 filed, newest first. Page 1 of 2.
Aug 2026
10 Aug · Results
May 2026
Feb 2026
Nov 2025
13 Nov · Results
Aug 2025
8 Aug · Results
May 2025
Jan 2025
11 Jan · Results
Nov 2024
Sep 2024
12 Sep · Results
Aug 2024
May 2024
Feb 2024
Nov 2023
Aug 2023
May 2023
Aug 2022
30 Aug · Results
Details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly <a href="https://www.bseindia.com/stock-share-price/meetings/voting-results/538965 ....
May 2022
Feb 2022
Nov 2021
Oct 2021
Sep 2021
30 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Aug 2021
Jun 2021
Feb 2021
Dec 2020
29 Dec · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Nov 2020
Sep 2020
14 Sep · Results
Jun 2020
Feb 2020
Nov 2019
Sep 2019
30 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
May 2019
Feb 2019
Nov 2018
Oct 2018
1 Oct · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Aug 2018
24 Aug · Results
Details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Jun 2018
Feb 2018
Dec 2017